CN105288831A - 一种中空管状的可生物降解型给药系统及其制备方法 - Google Patents
一种中空管状的可生物降解型给药系统及其制备方法 Download PDFInfo
- Publication number
- CN105288831A CN105288831A CN201410243231.5A CN201410243231A CN105288831A CN 105288831 A CN105288831 A CN 105288831A CN 201410243231 A CN201410243231 A CN 201410243231A CN 105288831 A CN105288831 A CN 105288831A
- Authority
- CN
- China
- Prior art keywords
- medicine
- hollow tubular
- supplying system
- drug
- biodegradable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 229940079593 drug Drugs 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229920002988 biodegradable polymer Polymers 0.000 claims abstract description 35
- 239000004621 biodegradable polymer Substances 0.000 claims abstract description 35
- 229920000642 polymer Polymers 0.000 claims abstract description 27
- 230000015556 catabolic process Effects 0.000 claims abstract description 13
- 238000006731 degradation reaction Methods 0.000 claims abstract description 13
- 238000003825 pressing Methods 0.000 claims abstract description 8
- 238000011068 loading method Methods 0.000 claims abstract description 7
- 238000001746 injection moulding Methods 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 5
- 210000001124 body fluid Anatomy 0.000 claims abstract description 4
- 239000010839 body fluid Substances 0.000 claims abstract description 4
- 238000000465 moulding Methods 0.000 claims abstract description 4
- 238000006065 biodegradation reaction Methods 0.000 claims description 59
- 239000000463 material Substances 0.000 claims description 33
- 241001597008 Nomeidae Species 0.000 claims description 8
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 6
- 238000007920 subcutaneous administration Methods 0.000 claims description 6
- 229940126586 small molecule drug Drugs 0.000 claims description 5
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 claims description 5
- 241000790917 Dioxys <bee> Species 0.000 claims description 4
- 238000004132 cross linking Methods 0.000 claims description 4
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims description 4
- 239000002398 materia medica Substances 0.000 claims description 4
- 238000007493 shaping process Methods 0.000 claims description 4
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims description 3
- 208000024827 Alzheimer disease Diseases 0.000 claims description 3
- 206010039966 Senile dementia Diseases 0.000 claims description 3
- 230000000202 analgesic effect Effects 0.000 claims description 3
- 230000003509 anti-fertility effect Effects 0.000 claims description 3
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 3
- 230000000259 anti-tumor effect Effects 0.000 claims description 3
- 201000000980 schizophrenia Diseases 0.000 claims description 3
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 3
- 238000009747 press moulding Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 238000005516 engineering process Methods 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 238000001125 extrusion Methods 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 238000006116 polymerization reaction Methods 0.000 abstract description 3
- 238000013268 sustained release Methods 0.000 abstract description 3
- 239000012620 biological material Substances 0.000 abstract description 2
- 230000001276 controlling effect Effects 0.000 abstract description 2
- 238000003181 co-melting Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 22
- 239000000203 mixture Substances 0.000 description 16
- 239000000186 progesterone Substances 0.000 description 11
- 229960003387 progesterone Drugs 0.000 description 11
- 238000013270 controlled release Methods 0.000 description 6
- 229920002379 silicone rubber Polymers 0.000 description 6
- 239000004945 silicone rubber Substances 0.000 description 6
- 239000003937 drug carrier Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 description 4
- SIGSPDASOTUPFS-XUDSTZEESA-N gestodene Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](C=C4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 SIGSPDASOTUPFS-XUDSTZEESA-N 0.000 description 4
- 229960005352 gestodene Drugs 0.000 description 4
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 4
- 239000007943 implant Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 3
- -1 trimethylene carbonate-Acetic acid Chemical compound 0.000 description 3
- BXVGCNQIUDNXRC-UHFFFAOYSA-N 2-[2-methyl-4-(2-methylpropyl)phenyl]acetic acid Chemical compound CC(C)CC1=CC=C(CC(O)=O)C(C)=C1 BXVGCNQIUDNXRC-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- GXGJIOMUZAGVEH-UHFFFAOYSA-N Chamazulene Chemical group CCC1=CC=C(C)C2=CC=C(C)C2=C1 GXGJIOMUZAGVEH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930012538 Paclitaxel Natural products 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- 229960003328 benzoyl peroxide Drugs 0.000 description 2
- 239000012876 carrier material Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000000748 compression moulding Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 229960003530 donepezil Drugs 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 2
- 229960001395 fenbufen Drugs 0.000 description 2
- 229960003878 haloperidol Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 229960005489 paracetamol Drugs 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OFNZWAAUVOEYMK-UHFFFAOYSA-N 1,3-dioxan-2-one;oxepan-2-one Chemical compound O=C1OCCCO1.O=C1CCCCCO1 OFNZWAAUVOEYMK-UHFFFAOYSA-N 0.000 description 1
- JRFXQKZEGILCCO-UHFFFAOYSA-N 5,5-dimethyl-1,3-dioxan-2-one Chemical compound CC1(C)COC(=O)OC1 JRFXQKZEGILCCO-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ACOGMWBDRJJKNB-UHFFFAOYSA-N acetic acid;ethene Chemical group C=C.CC(O)=O ACOGMWBDRJJKNB-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000001946 anti-microtubular Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 238000011393 cytotoxic chemotherapy Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410243231.5A CN105288831B (zh) | 2014-06-03 | 2014-06-03 | 一种中空管状的可生物降解型给药系统及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410243231.5A CN105288831B (zh) | 2014-06-03 | 2014-06-03 | 一种中空管状的可生物降解型给药系统及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105288831A true CN105288831A (zh) | 2016-02-03 |
CN105288831B CN105288831B (zh) | 2019-11-08 |
Family
ID=55187079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410243231.5A Active CN105288831B (zh) | 2014-06-03 | 2014-06-03 | 一种中空管状的可生物降解型给药系统及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105288831B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106667897A (zh) * | 2017-02-16 | 2017-05-17 | 辽宁省计划生育科学研究院 | 一种生物降解型缓控释给药系统及其制备方法 |
CN107970522A (zh) * | 2017-11-24 | 2018-05-01 | 黑龙江工程学院 | 一种可降解金属基皮下载药埋置物及其制备方法 |
CN108452380A (zh) * | 2018-03-30 | 2018-08-28 | 北京湃生生物科技有限公司 | 一种负载药物的仿生管状材料 |
CN108514658A (zh) * | 2018-03-30 | 2018-09-11 | 北京湃生生物科技有限公司 | 一种仿生管状材料 |
CN108744038A (zh) * | 2018-03-30 | 2018-11-06 | 北京湃生生物科技有限公司 | 一种防粘连仿生修复膜 |
CN108771573A (zh) * | 2018-06-26 | 2018-11-09 | 柏为(武汉)医疗科技股份有限公司 | 一种可完全降解吸收的药物洗脱支架及其应用 |
CN109925538A (zh) * | 2018-04-19 | 2019-06-25 | 易浦润(上海)生物技术有限公司 | 一种弹性膜、其制备方法和应用 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020120326A1 (en) * | 2000-12-22 | 2002-08-29 | Gene Michal | Ethylene-carboxyl copolymers as drug delivery matrices |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
CN1586655A (zh) * | 2004-07-02 | 2005-03-02 | 清华大学 | x射线下可视的多层药物复合可降解胆道支架的制备方法 |
US20060067995A1 (en) * | 2004-07-02 | 2006-03-30 | Heng Wan Sia P | Topical and/or transdermal bioactive compound delivery system |
CN102284088A (zh) * | 2011-07-27 | 2011-12-21 | 中国科学院长春应用化学研究所 | 可吸收血管支架 |
CN102294076A (zh) * | 2011-06-02 | 2011-12-28 | 中国医学科学院生物医学工程研究所 | 下肢缺血血运重建生物可降解性中药缓释置入物及制备 |
CN102552992A (zh) * | 2011-09-22 | 2012-07-11 | 上海微特生物技术有限公司 | 一种多层复合管材及其制造方法和应用 |
CN102743328A (zh) * | 2012-04-26 | 2012-10-24 | 辽宁省计划生育科学研究院 | 一种生物降解材料宫内缓控释给药系统及其制备方法 |
CN102911350A (zh) * | 2011-09-27 | 2013-02-06 | 辽宁省计划生育科学研究院 | 一种六元环状碳酸酯在生物降解材料中的应用 |
CN102989044A (zh) * | 2012-12-10 | 2013-03-27 | 辽宁省计划生育科学研究院 | 一种可生物降解医用高分子管材及其制备方法 |
CN103705986A (zh) * | 2012-10-09 | 2014-04-09 | 上海微创医疗器械(集团)有限公司 | 可降解的血管支架及其制造方法 |
-
2014
- 2014-06-03 CN CN201410243231.5A patent/CN105288831B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020120326A1 (en) * | 2000-12-22 | 2002-08-29 | Gene Michal | Ethylene-carboxyl copolymers as drug delivery matrices |
US20040024450A1 (en) * | 2002-04-24 | 2004-02-05 | Sun Biomedical, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
CN1586655A (zh) * | 2004-07-02 | 2005-03-02 | 清华大学 | x射线下可视的多层药物复合可降解胆道支架的制备方法 |
US20060067995A1 (en) * | 2004-07-02 | 2006-03-30 | Heng Wan Sia P | Topical and/or transdermal bioactive compound delivery system |
CN102294076A (zh) * | 2011-06-02 | 2011-12-28 | 中国医学科学院生物医学工程研究所 | 下肢缺血血运重建生物可降解性中药缓释置入物及制备 |
CN102284088A (zh) * | 2011-07-27 | 2011-12-21 | 中国科学院长春应用化学研究所 | 可吸收血管支架 |
CN102552992A (zh) * | 2011-09-22 | 2012-07-11 | 上海微特生物技术有限公司 | 一种多层复合管材及其制造方法和应用 |
CN102911350A (zh) * | 2011-09-27 | 2013-02-06 | 辽宁省计划生育科学研究院 | 一种六元环状碳酸酯在生物降解材料中的应用 |
CN102743328A (zh) * | 2012-04-26 | 2012-10-24 | 辽宁省计划生育科学研究院 | 一种生物降解材料宫内缓控释给药系统及其制备方法 |
CN103705986A (zh) * | 2012-10-09 | 2014-04-09 | 上海微创医疗器械(集团)有限公司 | 可降解的血管支架及其制造方法 |
CN102989044A (zh) * | 2012-12-10 | 2013-03-27 | 辽宁省计划生育科学研究院 | 一种可生物降解医用高分子管材及其制备方法 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106667897A (zh) * | 2017-02-16 | 2017-05-17 | 辽宁省计划生育科学研究院 | 一种生物降解型缓控释给药系统及其制备方法 |
CN107970522A (zh) * | 2017-11-24 | 2018-05-01 | 黑龙江工程学院 | 一种可降解金属基皮下载药埋置物及其制备方法 |
CN108452380A (zh) * | 2018-03-30 | 2018-08-28 | 北京湃生生物科技有限公司 | 一种负载药物的仿生管状材料 |
CN108514658A (zh) * | 2018-03-30 | 2018-09-11 | 北京湃生生物科技有限公司 | 一种仿生管状材料 |
CN108744038A (zh) * | 2018-03-30 | 2018-11-06 | 北京湃生生物科技有限公司 | 一种防粘连仿生修复膜 |
CN109925538A (zh) * | 2018-04-19 | 2019-06-25 | 易浦润(上海)生物技术有限公司 | 一种弹性膜、其制备方法和应用 |
CN109925538B (zh) * | 2018-04-19 | 2022-03-01 | 易浦润(上海)生物技术有限公司 | 一种弹性膜、其制备方法和应用 |
CN108771573A (zh) * | 2018-06-26 | 2018-11-09 | 柏为(武汉)医疗科技股份有限公司 | 一种可完全降解吸收的药物洗脱支架及其应用 |
CN108771573B (zh) * | 2018-06-26 | 2020-10-13 | 柏为(武汉)医疗科技股份有限公司 | 一种可完全降解吸收的药物洗脱支架及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105288831B (zh) | 2019-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105288831A (zh) | 一种中空管状的可生物降解型给药系统及其制备方法 | |
US4033938A (en) | Polymers of unsymmetrically substituted 1,4-dioxane-2,5-diones | |
DE2602994C2 (de) | Homo- oder Copolymere und Verfahren zu deren Herstellung | |
US3960152A (en) | Surgical sutures of unsymmetrically substituted 1,4-dioxane-2,5-diones | |
RU2010111356A (ru) | Медицинские устройства и способы, включающие полимеры, содержащие биологически активные вещества | |
JP2004511431A (ja) | 生物活性物質を含む生分解性ビヒクルおよび送達システム | |
JP2007130417A (ja) | 経皮投与装置 | |
AU2008245710B2 (en) | Implant device release agents and methods of using same | |
EP3569260A1 (en) | Non-woven fabric bandage and a method for the production of a non-woven fabric bandage | |
CN1857730B (zh) | 带微孔的多腔体可降解植入式药物控释载体及其制备工艺 | |
CN101947353B (zh) | 含有功能性纳米涂层的可降解医用复合导管及其制备方法 | |
CN100379420C (zh) | 一种用于戒毒的长效缓释制剂及其制备方法和用途 | |
CA2969171A1 (en) | Drug delivery system for delivery of acid sensitive drugs | |
CN101491494A (zh) | 一种兽用吡喹酮缓释植入剂及其制备方法 | |
CN102989044B (zh) | 一种可生物降解医用高分子管材及其制备方法 | |
CN104474595B (zh) | 具有辅助治疗食管癌功能的双层复合覆膜的食管支架的制备方法 | |
CN1600307A (zh) | 一种替莫唑胺控释给药系统 | |
CN113289062B (zh) | 一种溶剂沉淀型原位凝胶注射植入剂及应用 | |
CN101926783B (zh) | 药物缓慢控制释放体及制备方法 | |
AU2011240364B2 (en) | Cannula device and method and device for providing a cannula device with an implant | |
CN101007171A (zh) | 家犬驱虫骨架型缓释植入剂及制备方法 | |
CN103446041A (zh) | 一种亮丙瑞林缓控释药棒及其制备方法 | |
CN111939329A (zh) | 一种3d打印plga微球骨可降解生物导管的制作方法 | |
CN2870885Y (zh) | 长效降血压埋植棒 | |
CN115590810B (zh) | 分段式可溶性微针溶液、应用和可溶性微针及其制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Liqun Inventor after: Li Jianxin Inventor before: Li Jianxin Inventor before: Yang Liqun |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210622 Address after: 110031 no.10-4, Puhe street, Huanggu District, Shenyang City, Liaoning Province Patentee after: Yang Liqun Address before: 110031, No. 10, Po River Street, Huanggu District, Liaoning, Shenyang Patentee before: LIAONING Research Institute OF FAMILY PLANNING |
|
TR01 | Transfer of patent right |